Publications

5677 Results

Phase II study of docetaxel and trametinib in patients with G12C and non-G12C KRAS mutation positive recurrent non-small cell lung cancer (NSCLC) (SWOG S1507, NCT)

Authors
S Gadgeel;J Miao;J Riess;P Mack;G Gerstner;T Burns;A Taj;W Akerley;K Dragnev;N Laudi;J Moon;JE Gray;DR Gandara;KL Kelly
Journal / Conference
Clinical Cancer Research May 26;CCR-22-3947. doi: 10.1158/1078-0432.CCR-22-3947. Online ahead of print
Year
2023
Research Committee(s)
Lung
PMID
PMID37233987
PMC
PMC10526968
Study Number(s)
S1507

Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG)

Authors
S Lee;W Fan;A Wang;R Vaidya;M Redman;S Gettinger;L Bazhenova;R Herbst;D Hershman;J Unger
Journal / Conference
JCO Clinical Cancer Informatics Apr;7:e2200165
Year
2023
Research Committee(s)
Lung
PMID
PMID37084329
PMC
PMC10281446
Study Number(s)
S1400I

Subclonal TP53 mutation are frequent and predict resistance to radio-immunotherapy in follicular lymphoma

Authors
R Burack;H Li;D Adlowitz;J Spence;L Rimsza;M Shadman;C Spier;M Kaminski;J Leonard;M LeBlanc;S Smith;J Friedberg
Journal / Conference
Blood Advances Sep 12;7(17):5082-5090
Year
2023
Research Committee(s)
Lymphoma
PMID
PMID37379264
PMC
PMC10471938
Study Number(s)
S0016

The effect of ctDNA Tumor Fraction (TF) on overall survival and concordance between tissue genomics and ctDNA in Lung-MAP

Authors
P Mack;M Redman;D Kozono;S Callis;H Tukachinsky;K Tolba;J Neal;S Waqar;K Dragnev;C Aggarwal;F Hirsch;J Patel;R Herbst;A Chiang;K Reckamp;K Kelly;H Borghaei;J Gray;D Gandara
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 9035); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), poster session
Year
2023
Research Committee(s)
Lung
Study Number(s)
LUNGMAP

ECOG-ACRIN LUNG-MAP S1900E Substudy (NCT04625647): A Phase II Study of Sotorasib in Participants (Pts) With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous (Non-sq) Non-Small Cell Lung Cancer (NSCLC)

Authors
S Padda;M Redman;D Gerber;T Stinchcombe;S Waqar;T Leal;K Minichiello;K Reckamp;R Herbst;H Borghaei;J Brahmer;J Gray;K Kelly;S Ramalingam;J Neal
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr TPS9143); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), tip, poster session
Year
2023
Research Committee(s)
Lung
Study Number(s)
S1900E

SWOG S1929: Phase II Randomized Study of Maintenance Atezolizumab (A) Versus Atezolizumab + Talazoparib (AT) in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Authors
N Abdel Karim;J Miao;K Reckamp;C Gay;L Byers;Y Zhao;M Redman;D Carrizosa;W Wang;W Petty;K Mehta;B Faller;E Agamah;S Kasbari;Rajini Malisetti;A Kumar;J Schallenkamp;K Alluri;J Gray;K Kelly
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 8504); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), oral
Year
2023
Research Committee(s)
Lung
Study Number(s)
S1929

Chemotherapy Induced Peripheral Neuropathy (CIPN) due to Paclitaxel versus Docetaxel in Patients with Early-Stage Breast Cancer Receiving Taxane Therapy: SWOG S1714 (NCT# 03939481)

Authors
M Trivedi;J Unger;D Hershman;A Darke;D Hertz;T Brannagan;S Smith;B Schneider;W Irvin;A Hathaway;A Vander Woude;V Gudena;NL Henry;M Fisch
Journal / Conference
J Clin Oncol 41, 2023 (suppl 16; abstr 12003); ASCO Annual Meeting (June 2-6, 2023, Chicago, IL), oral
Year
2023
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S1714

Image analysis-based tumor infiltrating lymphocyte measurement predicts pathologic complete response to neoadjuvant chemotherapy in breast cancer (SWOG S0800)

Authors
K Fanucci;K Blenman;Y Bai;V Pelekanou;Z Nahleh;S Shafi;S Burela;W Barlow;P Sharma;A Thompson;A Godwin;D Rimm;G Hortobagyi;L Pusztai
Journal / Conference
NPJ Breast Cancer May 13;9(1):38
Year
2023
Research Committee(s)
Breast
PMID
PMID37179362
PMC
PMC10182981
Study Number(s)
S0800

Feasibility and Acceptability of an Online Intervention to Enhance Hopefulness Among Oncology Professionals

Authors
B Corn;D Feldman;I Subbiah;PD Corn;M Bakitas;R Krouse;M Hudson;L Fowler;V Fraser;C Siegal;R Agarwal;J Ge;J Parajuli;J Myers;M O'Rourke
Journal / Conference
JNCI Cancer Spectrum May 2;7(3):pkad030
Year
2023
PMID
PMID37104744
PMC
PMC10208111

Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer

Authors
R Cannioto;K Attwood;E Davis;L Mendicino;A Hutson;G Zirpoli;L Tang;N Nair;W Barlow;D Hershman;J Unger;H Moore;C Issacs;T Hobday;G Hortobagyi;J Gralow;K Albain;GT Budd;C Ambrosone
Journal / Conference
JAMA Network Open May 1;6(5):e2311673
Year
2023
Research Committee(s)
Breast
PMID
PMID37140922
PMC
PMC10160875
Study Number(s)
S0221